HopeAI

HopeAI is a Mayo Clinic-backed, AI-native startup focused on building an end-to-end AI drug development platform. Our core focus is evidence-based clinical trial design, combining comprehensive global clinical evidence, patient-level insights, statistical rigor, and expert-validated AI workflows to help biopharma teams make faster and more defensible decisions throughout clinical development. HopeAI has established collaborations with global pharmaceutical partners to support clinical development programs and improve the probability of trial success.